GlassScriptPhysician profile
David Farr
NPI 1548529241
$9,561.05
in general payments reported to CMS, 2019-2025
40 companies · $1,057 in 2025
The $1,057 reported for 2025 was more than what 88% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $972 · 2022: $2,573 · 2023: $1,734 · 2024: $3,226 · 2025: $1,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,120 · Travel and Lodging: $1,872 · Education: $24.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,120.03 |
| Travel and Lodging | $1,872.36 |
| Education | $24.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,996.72 | 2022-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $1,462.89 | 2022-2025 | Ams 700 Cxr Rte Kit, Xpeeda Dsl Fiber, Rezum Generator |
| Sumitomo Pharma America, INC. | $756.34 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $411.20 | 2021-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $311.33 | 2021-2025 | Xtandi |
| Myriad Genetic Laboratories, INC. | $310.92 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $288.52 | 2021-2025 | Provenge |
| Abbvie INC. | $276.43 | 2021-2025 | |
| C. R. Bard, INC. & Subsidiaries | $276.11 | 2023 | Bard Urinary Drainage Bag |
| Myovant Sciences INC. | $271.14 | 2021-2022 | |
| Pfizer INC. | $241.67 | 2022-2025 | |
| Rochester Medical Corporation | $205.15 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $166.09 | 2022-2025 | Pylarify |
| Endo Pharmaceuticals INC. | $127.65 | 2021-2023 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $121.96 | 2021-2025 | Jelmyto |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $114.87 | 2021-2023 | Urolift |
| Otsuka America Pharmaceutical, INC. | $103.20 | 2025 | Rexulti |
| Procept Biorobotics Corporation | $100.30 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Bayer Healthcare Pharmaceuticals INC. | $98.07 | 2024-2025 | |
| Olympus America INC. | $97.67 | 2023-2025 | Itind System |
| Medtronic, INC. | $89.42 | 2021-2022 | |
| Urovant Sciences INC | $65.57 | 2021-2022 | |
| Endo USA, INC. | $61.57 | 2024-2025 | Xiaflex |
| Tolmar, INC. | $60.16 | 2025 | Jatenzo, Eligard |
| Ferring Pharmaceuticals INC. | $57.31 | 2024-2025 | Adstiladrin |
| 180 Medical, INC. | $53.64 | 2024 | Cure Catheter, Gentlecath |
| Novartis Pharmaceuticals Corporation | $53.10 | 2024-2025 | |
| Blue Earth Diagnostics | $49.78 | 2021-2022 | |
| Coloplast Corp | $46.75 | 2021 | |
| Intuitive Surgical, INC. | $34.16 | 2022 | |
| Convatec INC. | $33.75 | 2021 | |
| Laborie Medical Technologies Corp. | $32.12 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Ethicon US, LLC | $31.42 | 2021-2025 | Echelon Flex |
| Inspire Medical Systems, INC. | $30.06 | 2024 | Inspire |
| Sun Pharmaceutical Industries INC. | $28.79 | 2024 | |
| Baxter Healthcare | $24.43 | 2025 | Floseal |
| Tolmar Pharmaceuticals, INC. | $22.13 | 2022 | |
| Immunitybio, INC. | $21.19 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $15.63 | 2022 | |
| Allergan, INC. | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Farr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.